help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergholm, R.
Right arrow Articles by Yki-Järvinen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergholm, R.
Right arrow Articles by Yki-Järvinen, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 3 1403-1409
Copyright © 2001 by The Endocrine Society


Comments

Insulin Sensitivity Regulates Autonomic Control of Heart Rate Variation Independent of Body Weight in Normal Subjects1

R. Bergholm, J. Westerbacka, S. Vehkavaara, A. Seppälä-Lindroos, T. Goto and H. Yki-Järvinen

Division of Diabetes, Department of Medicine, University of Helsinki, Helsinki 00290, Finland

Address all correspondence and requests for reprints to: Hannele Yki-Järvinen, M.D., Department of Medicine, University of Helsinki, P.O. Box 340, 00029 HUCH, Helsinki, Finland. E-mail: ykijarvi{at}helsinki.fi

Abstract

It is unclear whether insulin sensitivity independent of body weight regulates control of heart rate variation (HRV) by the autonomic nervous system.

Insulin action on whole-body glucose uptake (M-value) and heart rate variability were measured in 21 normal men. The subjects were divided into 2 groups [normally insulin sensitive (IS, 8.0 ± 0.4 mg/kg·min) and less insulin sensitive (IR, 5.1 ± 0.3 mg/kg·min)] based on their median M-value (6.2 mg/kg·min). Spectral power analysis of heart rate variability was performed in the basal state and every 30 min during the insulin infusion.

The IS and IR groups were comparable, with respect to age (27 ± 2 vs. 26 ± 2 yr), body mass index (22 ± 1 vs. 23 ± 1 kg/m2), body fat (13 ± 1 vs. 13 ± 1%), systolic (121 ± 16 vs. 117 ± 14 mm Hg) and diastolic (74 ± 11 vs. 73 ± 11 mm Hg) blood pressures, and fasting plasma glucose (5.4 ± 0.1 vs. 5.5 ± 0.1 mmol/L) concentrations. Fasting plasma insulin was significantly higher in the IR (30 ± 4 pmol/L) than in the IS (17 ± 3 pmol/L, P < 0.05) group. In the IS group, insulin significantly increased the normalized low-frequency (LFn) component, a measure of predominantly sympathetic nervous system activity, from 36 ± 5 to 48 ± 4 normalized units (nu; 0 vs. 30–120 min, P < 0.001); whereas the normalized high-frequency (HFn) component, a measure of vagal control of HRV, decreased from 66 ± 9 to 48 ± 5 nu (P < 0.001). No changes were observed in either the normalized LF component [35 ± 5 vs. 36 ± 2 nu, not significant (NS)] or the normalized HF component (52 ± 6 vs. 51 ± 4 nu, NS) in the IR group. The ratio LF/HF, a measure of sympathovagal balance, increased significantly in the IS group (0.92 ± 0.04 vs. 1.01 ± 0.04, P < 0.01) but remained unchanged in the IR group (0.91 ± 0.04 vs. 0.92 ± 0.03, NS). Heart rate and systolic and diastolic blood pressures remained unchanged during the insulin infusion in both groups.

We conclude that insulin acutely shifts sympathovagal control of HRV toward sympathetic dominance in insulin-sensitive, but not in resistant, subjects. These data suggest that sympathetic overactivity is not a consequence of hyperinsulinemia.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Kotronen and H. Yki-Jarvinen
Fatty Liver: A Novel Component of the Metabolic Syndrome
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 27 - 38.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J-M Gonzalez-Clemente, C Vilardell, M Broch, A Megia, A Caixas, O Gimenez-Palop, C Richart, I Simon, A Martinez-Riquelme, J Arroyo, et al.
Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes
Eur. J. Endocrinol., July 1, 2007; 157(1): 31 - 38.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Petrova, R. Townsend, and K. L. Teff
Prolonged (48-Hour) Modest Hyperinsulinemia Decreases Nocturnal Heart Rate Variability and Attenuates the Nocturnal Decrease in Blood Pressure in Lean, Normotensive Humans
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 851 - 859.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
V. A. F. Bisquolo, C. G. Cardoso Jr., K. C. Ortega, J. L. Gusmao, T. Tinucci, C. E. Negrao, B. L. Wajchenberg, D. Mion Jr, and C. L. M. Forjaz
Previous exercise attenuates muscle sympathetic activity and increases blood flow during acute euglycemic hyperinsulinemia
J Appl Physiol, March 1, 2005; 98(3): 866 - 871.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Sundell, P. Nuutila, H. Laine, M. Luotolahti, K. Kalliokoski, O. Raitakari, and J. Knuuti
Dose-Dependent Vasodilating Effects of Insulin on Adenosine-Stimulated Myocardial Blood Flow
Diabetes, April 1, 2002; 51(4): 1125 - 1130.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Westerbacka, A. Seppala-Lindroos, and H. Yki-Jarvinen
Resistance to Acute Insulin Induced Decreases in Large Artery Stiffness Accompanies the Insulin Resistance Syndrome
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5262 - 5268.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society